Page 124 - ESHRE2019

Management by type of EH
EH without atypia / BEH
•
1. 1.
Risk of progression of hyperplasia without atypia to EC has not been well studied
Surveillance, when:
– normal menses
– no risk factors
Progestin therapy:
– for 6 months
– oral
– LNG‐IUD (52/5)  treatment of choice
122
119